Calprotectin in inflammatory rheumatic diseases. Clinical and experimental studies

Author：

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.27, Iss.1, 1998-05, pp. : 87-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases

By Tursi Antonio Elisei Walter Giorgetti GianMarco Picchio Marcello Brandimarte Giovanni

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 11, 2013-11 ,pp. : 1359-1360

Informa Healthcare

Access to resources Recommend Favorite

Accelerated atherosclerosis in inflammatory rheumatic diseases

By Haskard DO

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 5, 2004-10 ,pp. : 281-292

Informa Healthcare

Access to resources Recommend Favorite

Rheumatic Manifestations Associated with Inflammatory Bowel Diseases

Current Rheumatology Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 47-56

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical application of etanercept in Chinese patients with rheumatic diseases

By Chou Chung-Tei

Modern Rheumatology, Vol. 16, Iss. 4, 2006-08 ,pp. : 206-213

Springer Publishing Company

Access to resources Recommend Favorite

The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases

Current Vascular Pharmacology, Vol. 8, Iss. 4, 2010-07 ,pp. : 437-449

Bentham Science Publishers

Access to resources Recommend Favorite